Reuters logo
BRIEF-Ritter Pharmaceuticals announces issuance of new patents for its lactose intolerance treatment, RP-G28
May 2, 2017 / 6:31 PM / 7 months ago

BRIEF-Ritter Pharmaceuticals announces issuance of new patents for its lactose intolerance treatment, RP-G28

May 2 (Reuters) - Ritter Pharmaceuticals Inc :

* Ritter Pharmaceuticals announces issuance of new patents for its lactose intolerance treatment, RP-G28, and provides an update on its path forward into Phase 3

* Will be holding an end of Phase 2 meeting with FDA to present and discuss Phase 3 plan for RP-G28 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below